華邦健康(002004.SZ)子公司獲得苯磺貝他斯汀片藥品註冊批件
格隆匯12月30日丨華邦健康(002004.SZ)公佈,公司全資子公司重慶華邦製藥有限公司(“華邦製藥”)於近日獲得國家藥品監督管理局核准簽發的化學藥品苯磺貝他斯汀片的《藥品註冊批件》。
藥品名稱:苯磺貝他斯汀片;英文名/拉丁名:Bepotastine Besilate Tablets;劑型:片劑;規格:10mg;申請事項:國產藥品註冊;註冊分類:化學藥品第4類;受理號:CYHS1700626渝;藥品批准文號:國藥準字H20193370。
苯磺貝他斯汀是一種高度選擇性的組胺H1受體拮抗劑(反向激動劑),能夠源頭控制組胺釋放,具有多重抗過敏作用,對於蕁麻疹、瘙癢性皮膚病、皮炎濕疹等皮膚相關的過敏性疾病及過敏性鼻炎等有着確切的療效。
苯磺貝他斯汀片為《國家基本醫療保險、工傷保險和生育保險目錄(2019年版)》乙類藥品,華邦製藥為國內首家獲得該註冊批件的企業。
苯磺貝他斯汀片藥品註冊批件的取得進一步豐富了公司抗過敏治療產品種類,對進一步優化公司產品結構有着積極的意義,隨着該產品市場佔有率的逐步增加,對公司業績的提升將產生積極影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.